 | Up a level |
Maurer, M; Magerl, M; Betschel, S; Aberer, W; Ansotegui, I J; Aygören-Pürsün, E; Banerji, A; Bara, N A; Boccon-Gibod, I; Bork, K; Bouillet, L; Boysen, H B; Brodszki, N; Busse, P J; Bygum, A; Caballero, T; Cancian, M; Castaldo, A; Cohn, D M; Csuka, D; ... (2023). [Not Available]. Arerugi = [Allergy], 72(3), pp. 237-272. 10.15036/arerugi.72.237
Maurer, M; Magerl, M; Betschel, S; Aberer, W; Ansotegui, I J; Aygören-Pürsün, E; Banerji, A; Bara, N A; Boccon-Gibod, I; Bork, K; Bouillet, L; Boysen, H B; Brodszki, N; Busse, P J; Bygum, A; Caballero, T; Cancian, M; Castaldo, A; Cohn, D M; Csuka, D; ... (2023). [Not Available]. Arerugi = [Allergy], 72(8), p. 1084. Japanese Society of Allergology 10.15036/arerugi.72.1084
Maurer, Marcus; Magerl, Markus; Betschel, Stephen; Aberer, Werner; Ansotegui, Ignacio J; Aygören-Pürsün, Emel; Banerji, Aleena; Bara, Noémi-Anna; Boccon-Gibod, Isabelle; Bork, Konrad; Bouillet, Laurence; Boysen, Henrik Balle; Brodszki, Nicholas; Busse, Paula J; Bygum, Anette; Caballero, Teresa; Cancian, Mauro; Castaldo, Anthony J; Cohn, Danny M; Csuka, Dorottya; ... (2022). The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update. World Allergy Organization journal, 15(3), p. 100627. Wolters Kluwer Health Lippincott Williams & Wilkins 10.1016/j.waojou.2022.100627
Dalakas, Marinos C.; Späth, Peter J. (2021). The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors. Therapeutic advances in neurological disorders, 14, p. 1756286421997381. Sage 10.1177/1756286421997381
Wahn, V; Aberer, W; Aygören-Pürsün, E; Bork, K; Eberl, W; Faßhauer, M; Krüger, R; Magerl, M; Martinez-Saguer, I; Späth, P.; Staubach-Renz, P; Weber-Chrysochoou, C (2020). Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries. Pediatric allergy and immunology, 31(8), pp. 974-989. Wiley-Blackwell 10.1111/pai.13309
Dalakas, Marinos C; Alexopoulos, Harry; Späth, Peter J (2020). Complement in neurological disorders and emerging complement-targeted therapeutics. Nature reviews. Neurology, 16(11), pp. 601-617. Nature Publishing Group 10.1038/s41582-020-0400-0
Späth, Peter Julius (2018). Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates. In: Imbach, P. (ed.) Antibody Therapy (pp. 151-173). Springer 10.1007/978-3-319-68038-5_12
Wahn, Volker; Späth, Peter Julius (2018). Historical Aspects of Polyclonal IgG Preparations. In: Imbach, P. (ed.) Antibody Therapy (pp. 121-132). Springer 10.1007/978-3-319-68038-5_10
Späth, Peter Julius (2018). Current IgG Products and Future Perspectives. In: Imbach, P. (ed.) Antibody Therapy (pp. 175-202). Springer 10.1007/978-3-319-68038-5_13
Radonjic-Hoesli, Susanne; Wang, Xiaoliang; de Graauw, Elisabeth Louisa Maria; Stoeckle, Christina; Styp-Rekowska, Beata; Hlushchuk, Ruslan; Simon, Dagmar; Späth, Peter Julius; Yousefi, Shida; Simon, Hans-Uwe (2017). Adhesion-induced eosinophil cytolysis requires the receptor-interacting protein kinase 3 (RIPK3)-mixed lineage kinase-like (MLKL) signaling pathway, which is counterregulated by autophagy. The Journal of allergy and clinical immunology, 140(6), pp. 1632-1642. Elsevier 10.1016/j.jaci.2017.01.044
Späth, Peter Julius; Schneider, Christoph; von Gunten, Stephan (2017). Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations. Archivum immunologiae et therapiae experimentalis, 65(3), pp. 215-231. Springer 10.1007/s00005-016-0422-x
Pilch, Kjara S; Späth, Peter Julius; Yuki, Nobuhiro; Wakerley, Benjamin R (2017). Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases. Expert review of neurotherapeutics, 17(6), pp. 579-591. Expert Reviews 10.1080/14737175.2017.1282821
Lejeune, Alice; Martin, Luise; Santibanez, Sabine; Thee, Stephanie; Gratopp, Alexander; Späth, Peter Julius; Mankertz, Annette; Kallinich, Tilmann; von Bernuth, Horst (2017). Postexposure prophylaxis with intravenous immunoglobulin G prevents infants from getting measles. Acta paediatrica, 106(1), pp. 174-177. Wiley 10.1111/apa.13634
Sudo, Makoto; Miyaji, Kazuki; Späth, Peter Julius; Morita-Matsumoto, Kana; Yamaguchi, Yoshiki; Yuki, Nobuhiro (2016). Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies. International immunopharmacology, 40, pp. 11-15. Elsevier 10.1016/j.intimp.2016.08.019
Späth, Peter Julius; Granata, Guido; La Marra, Fabiola; Kuijpers, Taco W.; Quinti, Isabella (2015). On the Dark Side of Therapies with Immunoglobulin Concentrates: The Adverse Events. Frontiers in immunology, 6(11), p. 11. Frontiers Research Foundation 10.3389/fimmu.2015.00011
Kerr, Jacqueline; Quinti, Isabella; Eibl, Martha; Chapel, Helen; Späth, Peter Julius; Sewell, W A Carrock; Salama, Abdulgabar; van Schaik, Ivo N; Kuijpers, Taco W; Peter, Hans-Hartmut (2014). Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe. Frontiers in immunology, 5(629), p. 629. Frontiers Research Foundation 10.3389/fimmu.2014.00629
Sudo, Makoto; Yamaguchi, Yoshiki; Späth, Peter Julius; Matsumoto-Morita, Kana; Ong, Benjamin K.; Shahrizaila, Nortina; Yuki, Nobuhiro (2014). Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition. PLoS ONE, 9(9), e107772. Public Library of Science 10.1371/journal.pone.0107772
Sewell, W. A. Carrock; Kerr, Jacqueline; Behr-Gross, Marie-Emmanuelle; Peter, Hans-Hartmut; Kreuth Ig Working Group, ; Späth, Peter Julius (2014). European consensus proposal for immunoglobulin therapies. European journal of immunology, 44(8), pp. 2207-2214. Wiley-VCH
Späth, Peter Julius; Tamburin, Stefano; Borg, Christian; Caro, Xavier J.; Jann, Stefano; Clark, Alexander J.; Maginelli, Francesca; Sobue, Gen; Werhagen, Lars; Zanetta, Giampietro; Koike, Haruki; Vincent, Angela; Goebel, Andreas (2014). Immunoglobulin g for the treatment of chronic pain: report of an expert workshop. Pain medicine, 15(7), pp. 1072-1082. Wiley-Blackwell 10.1111/pme.12319
Späth, Peter Julius (2014). A novel use of intravenous immunoglobulin is not restricted to complement hypercatabolism because of factor H deficiency. Progress in transplantation, 24(2), p. 120. InnoVision Communications 10.7182/pit2014750
Späth, Peter Julius (2014). Report from a rare diseases event in Targu Mures, Romania. Romanian Review of Laboratory Medicine, 22(3), pp. 397-398. Romanian Association of Medical Laboratories
Späth, Peter Julius (2014). A glance on recent progresses in diagnosis and treatment of primary immunodeficiencies. Romanian Review of Laboratory Medicine, 22(3), pp. 297-309. Romanian Association of Medical Laboratories 10.2478/rrlm-2014-0034
Späth, Peter Julius (2014). Report on Congress Highlights 2013. Congress Report 2013.
Kempf, Christoph; Späth, Peter Julius (2013). Pathogen safety of Immunoglobulin Preparations. In: Clinical use of immunoglobulins (pp. 33-57). Bremen: UNI-med
Krudewig, J; Baumann, U; Bernuth von, H; Borte, M; Burkhard-Meier, U; Dueckers, G; Foerster-Waldl, E; Franke, K; Habermehl, P; Hönig, M; Kern, W; Kösters, K; Kugel, K; Lehrnbecher, T; Liese, J; Marks, R; Müller, G A; Müller, R; Nadal, D; Peter, H-H; ... (2012). [Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies]. Klinische Pädiatrie, 224(6), pp. 404-15. Stuttgart: Thieme 10.1055/s-0032-1323837
Charignon, Delphine; Späth, Peter; Martin, Ludovic; Drouet, Christian (2012). Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems. Expert opinion on pharmacotherapy, 13(15), pp. 2233-47. London: Informa Healthcare 10.1517/14656566.2012.723692
Späth, Peter J; Lutz, Hans U (2012). Naturally occurring antibodies/autoantibodies in polyclonal immunoglobulin concentrates. Advances in experimental medicine and biology, 750, pp. 239-261. Wien: Springer
Wahn, V; Aberer, W; Eberl, W; Faßhauer, M; Kühne, T; Kurnik, K; Magerl, M; Meyer-Olson, D; Martinez-Saguer, I; Späth, P; Staubach-Renz, P; Kreuz, W (2012). Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies. European journal of pediatrics, 171(9), pp. 1339-48. Berlin: Springer 10.1007/s00431-012-1726-4
Yuki, N; Watanabe, H; Nakajima, T; Späth, P J (2011). IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy. Journal of neurology, neurosurgery and psychiatry, 82(1), pp. 87-91. London: BMJ Publishing Group 10.1136/jnnp.2010.205856
Späth, Peter J; Hunziker, Thomas (2011). Will immunoglobulin therapy of autoimmune blistering skin diseases survive the new financial management of inpatients? Dermatology, 222(2), pp. 138-9. Basel: Karger 10.1159/000323006
Delforge, M; Farber, C M; Spath, P; Kaveri, S; Witte, T; Misbah, S A; Hübner, R; Haerynck, F; Latinne, D; Muylle, L; Toungouz, M; Deneys, V; Superior Health Council Belgium, (2011). Recommended indications for the administration of polyclonal immunoglobulin preparations. Acta clinica belgica, 66(5), pp. 346-60. Brussels: Acta clinica belgica 10.2143/ACB.66.5.2062586
Späth, P. J. (2011). Highlights from the 7th C1 Inhibitor Deficiency Workshop, Budapest, Hungary.
Lucas, Mary; Hugh-Jones, Ken; Welby, Angela; Misbah, Siraj; Spaeth, Peter; Chapel, Helen (2010). Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home. Journal of clinical immunology, 30 Suppl 1, S84-S89. New York, N.Y.: Springer 10.1007/s10875-010-9400-y
Bowen, Tom; Cicardi, Marco; Farkas, Henriette; Bork, Konrad; Longhurst, Hilary J; Zuraw, Bruce; Aygoeren-Pürsün, Emel; Craig, Timothy; Binkley, Karen; Hebert, Jacques; Ritchie, Bruce; Bouillet, Laurence; Betschel, Stephen; Cogar, Della; Dean, John; Devaraj, Ramachand; Hamed, Azza; Kamra, Palinder; Keith, Paul K; Lacuesta, Gina; ... (2010). 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy, asthma & clinical immunology, 6(1), p. 24. Hamilton, Ont.: B.C. Decker Inc.
Wais-Nöcker, B; Stiner, U; Farkas, H; Späth, P; Varga, L (2010). Klinische Facetten des hereditären Angioödems bei einem Schweizer Patientenkollektiv Praxis 99
Fernandez-Cruz, E; Kaveri, S V; Peter, H-H; Durandy, A; Cantoni, N; Quinti, I; Sorensen, R; Bussel, J B; Danieli, M G; Winkelmann, A; Bayry, J; Käsermann, F; Späth, P; Helbert, M; Salama, A; van Schaik, I N; Yuki, N (2009). 6th International Immunoglobulin Symposium: poster presentations. Clinical and experimental immunology, 158 Suppl 1(Suppl 1), pp. 60-67. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2249.2009.04028.x
Wahn, V; Späth, P J (2008). Komplementdefekte, Kinder und Jugendmedizin. Kinder- und Jugendmedizin, 3(2008), pp. 179-184. Stuttgart: Schattauer
Wahn, V; Späth, P (2008). Pathogen safety of immunoglubulin preparations. In: Clinical Use of Immunoglobulins, 1st Edtition (pp. 29-50). Bremen et al.: UNI-MED
Spaeth, P; Wahn, V (2007). Komplementdefekte. Allergologie, 30(2007), pp. 99-105. München-Deisenhofen: Dustri-Verlag
Poehlau, D; Przuntek, H; Sailer, M; Bethke, M; Koehler, J; Koenig, N; Heesen, C; Spaeth, P (2007). Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study. Multiple sclerosis journal, 13(2007), pp. 1107-1117. London: Sage 10.1177/1352458507078400
Vyse, T.J.; Späth, P.J.; Davies, K.A.; Morley, B.J.; Philippe, P.; Athanassiou, P.; Giles, C.M.; Walport, M.J. (1994). Hereditary complement factor I deficiency. QJM - an international journal of medicine, 87(7), pp. 385-401. Oxford University Press 10.1093/oxfordjournals.qjmed.a068946
